MarketsandMarkets: Global Minimally Invasive Surgery (MIS) Market Worth US$ 90.4 Billion by 2015.

DALLAS, Texas, September 16, 2010 – The 'Global Minimally Invasive Surgery Market (2010 – 2015)'
(www.marketsandmarkets.com/Market-Reports/minimally-invasive-276.html)
analyzes the MIS market by products, applications, technologies and studies
the major market drivers, restraints, and opportunities for the minimally
invasive surgery market in the U.S., Europe, APAC and ROW (Rest of the
World).

Browse market data tables and in-depth [...]

Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System

Transapical Implantation of a Percutaneous Aortic Tissue Valve Validates Trinity's Technology

REGENSBURG, Germany, September 16, 2010 – Transcatheter Technologies GmbH (TT), an innovative medical device
company that is developing a second-generation transcatheter aortic valve
prosthesis, announced today that its proprietary transapical aortic valve has
been successfully implanted in the acute porcine model.
The acute in [...]

ResMed Launches Smaller Alternative to the Full Face Mask for CPAP Treatment

Introducing Quattro FX, ResMed increases choice and comfort for sufferers of sleep apnoea

OSLO, Norway, September 16, 2010 – ResMed (NYSE: RMD), a leading developer, manufacturer, and distributor of
sleep and respiratory medical equipment today announced the launch of Quattro
FX Full Face Mask, a smaller alternative to the full face mask for use with
positive airway pressure [...]

Study Shows ResMed’s New CPAP Device Increases Patient Compliance

Clinical study confirms new features of S9 Series prolong patients' sleep by up to 30 minutes

OSLO, Norway, September 16, 2010 – ResMed (NYSE: RMD), a leading developer, manufacturer, and distributor of
sleep and respiratory medical equipment today announced the results of a
clinical study confirming that patients' compliance with sleep therapy
increases when using the ResMed's new [...]

Abbott to Present Data on Market-Leading XIENCE V(R) and Promising Vascular Pipeline at TCT 2010

ABBOTT PARK, Illinois, September 16, 2010 – — XIENCE V Data From the SPIRIT IV Trial to be Presented as a Late
Breaking Trial on Sept. 23

— Abbott's Vascular Pipeline Presentations to Include Data on the
MitraClip(R) System and the Bioresorbable Vascular Scaffold
Abbott (NYSE: ABT) today announced the [...]

CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010

WASHINGTON,, September 16, 2010 – CID s.r.l., a European company leader in interventional medicine, will
update interventional cardiologists on the status of their revolutionary drug
eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT
2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled
"Status of the CID Cre8 polymer-free DES program", will be [...]